Brian D. Koppy - May 9, 2022 Form 4 Insider Report for Cano Health, Inc. (CANO)

Role: Chief Financial Officer
Signature: /s/ David J. Armstrong, Attorney-in-Fact
Stock symbol: CANO
Transactions as of: May 9, 2022
Transactions value $: -$177,320
Form type: 4
Date filed: 5/12/2022, 09:04 PM
Previous filing: Mar 17, 2022
Next filing: Sep 2, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CANO	Class A Common Stock	Tax liability	-$177K	-40.5K	-5.16%	$4.38^*	744K	May 9, 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
F2	The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.8016 to $4.8897. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.8016 to $4.8897. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.